Entropy Technologies LP Has $2.46 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Entropy Technologies LP grew its position in Cardinal Health, Inc. (NYSE:CAH) by 32.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 17,829 shares of the company’s stock after acquiring an additional 4,334 shares during the period. Entropy Technologies LP’s holdings in Cardinal Health were worth $2,456,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Principal Financial Group Inc. lifted its stake in shares of Cardinal Health by 5.3% in the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock valued at $43,510,000 after acquiring an additional 15,956 shares during the last quarter. Kingswood Wealth Advisors LLC lifted its stake in shares of Cardinal Health by 17.2% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company’s stock valued at $429,000 after acquiring an additional 457 shares during the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Cardinal Health by 25.8% in the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company’s stock valued at $1,811,000 after acquiring an additional 2,694 shares during the last quarter. Golden State Wealth Management LLC lifted its stake in shares of Cardinal Health by 569.5% in the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock valued at $54,000 after acquiring an additional 336 shares during the last quarter. Finally, North Capital Inc. acquired a new position in shares of Cardinal Health during the first quarter worth $83,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Trading Up 2.6%

NYSE:CAH opened at $157.44 on Monday. The stock has a market capitalization of $37.58 billion, a price-to-earnings ratio of 24.56, a PEG ratio of 1.56 and a beta of 0.67. The firm has a fifty day simple moving average of $160.05 and a two-hundred day simple moving average of $143.96. Cardinal Health, Inc. has a 12 month low of $98.07 and a 12 month high of $168.44.

Analyst Ratings Changes

A number of research firms recently weighed in on CAH. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Morgan Stanley lifted their target price on Cardinal Health from $181.00 to $190.00 and gave the stock an “overweight” rating in a report on Wednesday, July 16th. Wells Fargo & Company raised Cardinal Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $136.00 to $179.00 in a report on Tuesday, June 3rd. Citigroup reissued a “neutral” rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Finally, Robert W. Baird increased their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the company an “outperform” rating in a research report on Friday, May 2nd. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus target price of $158.07.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.